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Accepted 6 September 2013The recent exponential increase in the rate of cesarean
sections has been associated with an increase in placentation
complications during subsequent pregnancies [1]. A cesarean
scar pregnancy (CSP) is a rare type of ectopic pregnancy that
results from faulty implantation within a previous cesarean
section scar. CSP may be life-threatening because of subse-
quent uterine rupture and uncontrolled hemorrhage that
require a hysterectomy.
Uterine arteriovenous malformation (AVM), which is an
abnormal connection between arteries and veins [2], can be
caused by iatrogenic events or pathologic pelvic conditions.
With the progress in imaging techniques such as computed
tomography (CT) and magnetic resonance angiography, uter-
ine AVM has been reported as one of the complications in CSP
cases [3e5]. Although the coexistence of uterine AVM and
CSP is potentially life-threatening, optimal management of
CSP with uterine AVM has not been determined because it is
so rare.
We report a case of CSP complicated by uterine AVM and
describe how the patient’s fertility was preserved using a
combined conservative management approach.
A 32-year-old patient (gravida 3, para 2) was referred for
suspicion of a gestational trophoblastic tumor. She had expe-
rienced persistent and painless vaginal bleeding for approxi-
mately 8 weeks, and ultrasound showed a tumor in the anterior
part of the uterus.
The patient had a first cesarean section delivery for breech
presentation. She gave birth to a second baby by elective ce-
sarean section 2 years prior to presentation for the current
problem. This pregnancy was followed by one missed abortion
during the first trimester, for which she underwent uterine
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slightly enlarged uterus were observed. Transvaginal ultra-
sound revealed a tumor of 60 mm  45 mm in size with an
unclear boundary on the previous cesarean section scar site.
The uterine cavity was empty and no fluid was found in the
cul-de sac. Color Doppler ultrasound showed numerous
tortuous blood vessels encompassing the tumor (Fig. 1).
The patient’s serum b-hCG level was 38,978 IU/L. As no
evidence of a clear gestation sac or embryo was found in the
mass, biopsy via uterine curettage was necessary for a defin-
itive diagnosis. Considering the highly vascularized tumor and
persistent vaginal bleeding, uterine artery embolization (UAE)
was first performed. A pelvic angiogram during UAE showed
that the mass was surrounded by multiple feeders from inter-
nal iliac arteries (Fig. 2). Uterine curettage was successfully
performed without abnormal bleeding, and histopathology
revealed necrotic placenta remnants and a conception product.
After this procedure, we monitored the patient weekly in
terms of serum b-hCG and transvaginal ultrasound. Her serum
b-hCG level plateaued after it had decreased to 1005 IU/L, and
a remaining mass with blood flow was still evident on trans-
vaginal ultrasound scans. Therefore, she was treated withFig. 1. Color Doppler ultrasound showing numerous tortuous blood vessels
encompassing the tumor in the anterior isthmic region of the uterus (arrow,
uterine fundus).
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Fig. 2. Pelvic angiogram showing uterine arteriovenous malformation supplied
by multiple feeders from branches of both internal iliac arteries at the initial
uterine artery embolization.
Fig. 3. During repeat uterine embolization, a pelvic angiogram of the left
uterine artery (arrow) revealed simultaneous filling of veins (arrow head) at the
arterial phase, which is a definitive diagnostic finding in arteriovenous
malformation.
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alternate days. After three courses, the patient’s serum b-hCG
decreased to <5 IU/L.
Approximately 4 weeks later, the patient visited the emer-
gency department with massive vaginal bleeding and her vital
signs were unstable. A CT scan showed a suspicious transverse
vascular malformation in the lower uterine segment. After the
patient and her husband both expressed a desire to preserve her
fertility, the decision was made to manage her condition
conservatively with UAE for emergent hemostasis. During
selective UAE, an angiogram of the left uterine artery showed
left aneurismal dilation, and AVM was observed in the right
uterine vein (Fig. 3). After selective UAE on both sides, the
vaginal bleeding lessened. Then uterine curettage was per-
formed to remove the remaining placenta tissue. The patient
resumed menstruation 3 months after curettage. In CT images
obtained 7 months postoperatively, no findings of remnants or
abnormal blood vessels were observed at the previous cesar-
ean scar site. The patient reported a regular and normal
menstruation cycle.
CSP, a rare type of ectopic pregnancy, is caused by blas-
tocyst implantation at the scar site for a previous cesarean
section. Scar tissue surrounding the gestational sac in CSP
may increase the susceptibility to placenta-associated com-
plications. Uterine AVM involves abnormal communication
between intramural branches of the uterine artery and the
myometrial venous plexus [2]. It can be caused by the inher-
ently erosive nature of synthiotrophoblastic tissue and chori-
onic villi during placental formation in CSP, in which the
defective decidual layer induces the development of abnormal
connections among vascular structures.
Most uterine AVM cases are congenital, but there have
been reports of acquired cases associated with previous uterinesurgical procedures or gestational trophoblastic disease [2].
Traumatic causes of arterial-to-venous connections include
endometrial curettage, cesarean section, and pelvic surgery.
Pelvic examination may reveal transcervical bleeding or a
palpable pulsating mass accompanied by lower abdominal
pain, dyspareunia, and anemia. Endometrial curettage per-
formed in patients with dysfunctional uterine bleeding
worsens vaginal hemorrhage by uterine AVM [6]. In the past,
uterine AVM was usually diagnosed through pathology ex-
aminations after hysterectomy. At present, Doppler ultrasound,
hysteroscopy, CT scanning, and magnetic resonance imaging
are used as diagnostic modalities, and a definite confirmation
can be made via angiography. Early venous drainage into the
endometrial or myometrial veins is a sign of arteriovenous
shunting observed in AVM [7].
Uterine AVM in CSP may be a natural response of the
inherently erosive trophoblastic tissue as it establishes an
adequate blood supply for the placenta. Restriction due to the
fibrous tissues and defective endometrium of cesarean scars
might promote abnormal angiogenesis. We incidentally
detected uterine AVM while performing a second UAE to
control massive hemorrhaging. During the first UAE, there
was no definitive evidence of AVM, but numerous tortuous
vascular components surrounded the tumor. A literature re-
view revealed three cases of CSP-associated uterine AVM
[3e5]. A definitive diagnosis was difficult in the past
because of limited vascular imaging modalities. However,
more cases of CSP-associated AVM have been reported
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for CSP.
The diagnosis of CSP has recently increased because of the
common use of early pregnancy transvaginal ultrasound and
the higher rate of cesarean delivery. Management for CSP,
however, is varied, and there has been difficulty in establishing
an optimal treatment. Medical treatment involves systemic or
local administration of MTX, injections of embryocides or
oral uterotonics such as mifepristone, and varying combined
regimens [8]. Uterine curettage or hysterectomy has been
occasionally used as a surgical approach. It has been reported
that aspiration of the ancillary surgical sac to prevent scar
rupture during medical treatments is effective in reducing the
size of the conception product [9]. Salvage treatments, such as
laparoscopic or hysteroscopic resection of the lesion, have
recently been used to preserve the uterus [10,11].
As an additional treatment, selective UAE has been
considered for patients who want to retain future fertility.
Risks include uterine infarction or ischemia and necrosis;
however, the majority of patients tolerate the UAE procedure
well [12,13]. Recurrent bleeding after UAE may develop,
depending on the presence of multiple arterial feeders or the
embolization medium, such as gelatin foam particles [5,14].
Despite these side effects, UAE is a minimally invasive pro-
cedure under local anesthesia or intravenous sedation that is
associated with lower morbidity, shorter hospitalization, and
uterine preservation [2]. In this case, UAE was performed
twice during conservative management. The first UAE was
performed as a prophylactic procedure to avoid massive
uterine bleeding during curettage for tissue biopsy. The repeat
embolization performed to stop massive bleeding revealed the
uterine AVM, which was successfully treated.
Uterine curettage is not recommended as a first-line
therapy for CSP, as it has either been unsuccessful or has
caused complications, including an increased risk of uterine
rupture and resulting secondary bleeding requiring hyster-
ectomy, because of the abnormally increased vascularity and
difficult surgical approach [8]. In addition, as the gestational
sac in CSP is not located in the endometrial cavity, uterine
curettage may be incomplete and leave remnants of invasive
trophoblastic tissue, which increases the risk of associated
morbidity.
Histopathologically, placental implantation in CSP is
similar to placenta accreta. The defective decidual layer of the
previous scar seems to be susceptible to faulty invasiveness of
the gestational product in CSP. In the case reported here, a
biopsy via uterine curettage was required for differential
diagnosis from gestational trophoblastic disease because no
definite finding of a conception-like gestation sac, embryo, or
double-ring sign was observed in the tumor. Although we do
not presume that conservative management of CSP is a direct
cause of AVM in this case, incomplete uterine curettage andremaining trophoblastic tissue may partly contribute to AVM
occurrence. We suspect that the remaining placental tissue
exhibited neovascularization and that the uterine AVM was
caused by an intrinsic attribute of the chorionic villi. In
addition, uterine curettage may be a traumatic factor in
causing artery-to-vein connections.
Our case of CSP complicated by uterine AVM was
managed with combined conservative treatment involving
systemic MTX, uterine curettage, and UAE, which preserved
the patient’s fertility. We propose that UAE should be
considered in CSP management for cases with numerous
tortuous vascularities. If remaining placental tissue is expected
after uterine curettage during conservative management of
CSP, clinicians should consider the development of an un-
common fatal complication, such as uterine AVM, despite
resolution of serum b-hCG.References
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